| Melisana AG - Vesoxx 1 mg/ml, Lösung zur intravesikalen Anwendung |
| 67983 | | 01 | | Vesoxx 1 mg/ml | | Lösung zur intravesikalen Anwendung | | G04BD04 | | Oxybutynin | | 27.05.2021 | | |
|
| Composition |
| oxybutynini hydrochloridum 1.004 mg corresp. oxybutyninum 0.911 mg, acidum hydrochloridum dilutum, natrii chloridum corresp. natrium 3.56 mg, aqua purificata, ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Lösung zur Intravesikalen Anwendung | | | | | | | | Active Agent | Dose |
|---|
| Oxybutynine Hydrochloride | 1.004 mg/ml correspond Oxybutynine 0.911 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Oxybutynine Hydrochloride | 10.04 mg |
| | | | Inactive agents |
|---|
| Acidum Hydrochloridum Dilutum | | Aqua Purificata | | Sodium Chloride |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 100 | 1107.22 | 1220.60 | B | | No | | 002 | 100 | 1107.22 | 1220.60 | B | SL | No |
|
